FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joachim Klosterkötter

Research Profile

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
S Kohl; Karsten Heekeren; Joachim Klosterkötter; J Kuhn
Prepulse inhibition in psychiatric disorders--apart from schizophrenia.
Jyrki Korkeila; T Laine; Don Linszen; Stephan Ruhrmann; R K R Salokangas; Tanja Svirskis; H von Reventlow; Max Birchwood; M Heinimaaa; Georg Juckel; Joachim Klosterkötter
Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis.
Ralf Tepest; Joachim Klosterkötter; Barbara Krug; Stephan Ruhrmann; Christopher J Schwarzbach; Kai Vogeley
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joachim Klosterkötter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Kohl; Karsten Heekeren; Joachim Klosterkötter; J Kuhn
Prepulse inhibition in psychiatric disorders--apart from schizophrenia.
Journal of psychiatric research 2013;47(4):445-52.
2013: Jyrki Korkeila; T Laine; Don Linszen; Stephan Ruhrmann; R K R Salokangas; Tanja Svirskis; H von Reventlow; Max Birchwood; M Heinimaaa; Georg Juckel; Joachim Klosterkötter
Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis.
European psychiatry : the journal of the Association of European Psychiatrists 2013;28(3):135-40.
2013: Ralf Tepest; Joachim Klosterkötter; Barbara Krug; Stephan Ruhrmann; Christopher J Schwarzbach; Kai Vogeley
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia.
European archives of psychiatry and clinical neuroscience 2013;263(1):15-24.
2013: Raimo K R Salokangas; Frauke Schultze-Lutter; Tanja Svirskis; Heinrich Graf von Reventlow; Max Birchwood; Peter M A J Dingemans; Tiina From; Markus Heinimaa; Georg Juckel; Joachim Klosterkötter; Don Linszen; Sinikka Luutonen; Dorien H Nieman; Paul Patterson; Stephan Ruhrmann
Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.
Social psychiatry and psychiatric epidemiology 2013;48(2):303-11.
2013: Paolo Fusar-Poli; Matcheri Keshavan; Joachim Klosterkötter; Thomas McGlashan; Patrick McGorry; Philip McGuire; Anita Riecher-Rössler; Stephan Ruhrmann; Frauke Schultze-Lutter; Larry J Seidman; Lucia Valmaggia; Eva Velthorst; Stephen Wood; Jean Addington; Andreas Bechdolf; Max Birchwood; Ilaria Bonoldi; Stefan Borgwardt; Tyrone Cannon; William T Carpenter; Barbara Cornblatt; Lieuwe de Haan; Alison Yung
The psychosis high-risk state: a comprehensive state-of-the-art review.
JAMA psychiatry (Chicago, Ill.) 2013;70(1):107-20.
2013: Dorien Nieman; P Patterson; Stephan Ruhrmann; R K R Salokangas; Frauke Schultze-Lutter; E Velthorst; H G von Reventlow; H E Becker; Max Birchwood; Lieuwe de Haan; Peter M A J Dingemans; Markus Heinimaa; A Heinz; G Juckel; Joachim Klosterkötter; Don Linszen; A Morrison
The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis.
Acta psychiatrica Scandinavica 2013;127(1):53-61.
2012: Alison R Yung; Jean Addington; G Paul Amminger; Andreas Bechdolf; Max Birchwood; Stefan Borgwardt; Tyrone D Cannon; Barbara A Cornblatt; Lieuwe de Haan; Paul French; Paolo Fusar-Poli; Matcheri S Keshavan; Joachim Klosterkötter; Jun Soo Kwon; Patrick D McGorry; Philip McGuire; Masafumi Mizuno; Anthony P Morrison; Anita Riecher-Rössler; Stephan Ruhrmann; Raimo K R Salokangas; Frauke Schultze-Lutter; Larry J Seidman; Michio Suzuki; Lucia Valmaggia; Mark van der Gaag; Stephen J Wood; Scott W Woods; Thomas H McGlashan
Whither the attenuated psychosis syndrome?
Schizophrenia bulletin 2012;38(6):1130-4.
2012: Stephan Ruhrmann; Mitja Bodatsch; Desire Hilboll; Dominika Julkowski; Joachim Klosterkötter; Alexandra Nikolaides; Frauke Schultz-Lutter
Chances and risks of predicting psychosis.
European archives of psychiatry and clinical neuroscience 2012;262 Suppl 2():S85-90.
2012: R Schennach; M Schmauss; Lutz G Schmidt; Florian Seemüller; E Rüther; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; S Klingberg; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; S Meyer; Hans-Jürgen Möller; D Naber; H Pfeiffer; Michael Riedel
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(8):625-33.
2012: Alkomiet Hasan; Joachim Klosterkötter; Marcin Labusga; Katrin Levold; Hendrik Müller; Thomas Schneider-Axmann; Thomas Wobrock; Peter Falkai; Christian Grefkes; Andreas Bechdolf
Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
Biological psychiatry 2012;72(9):744-51.
2012: Frauke Schultze-Lutter; Karen Winkler; Joachim Klosterkötter; Chantal Michel; Stephan Ruhrmann
Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis.
Early intervention in psychiatry 2012;6(4):389-98.
2012: Florian Seemüller; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingenberg; Joachim Klosterkötter; Ute Lewitzka; Wolfgang Maier; Andreas Mayr; Hans-Jürgen Möller; Richard Musil; Christian Ohmann; Michael Riedel; Rebecca Schennach; Ralf Schlösser; Andrea Schmitt; Frank Schneider
Akathisia and suicidal ideation in first-episode schizophrenia.
Journal of clinical psychopharmacology 2012;32(5):694-8.
2012: Leonhard Lennertz; Wolfgang Maier; Ralf Pukrop; Friederike Rampacher; Stephan Ruhrmann; Svenja Schulze-Rauschenbach; Andrea Vogeley; Peter Falkai; Joachim Klosterkötter; Michael Wagner
Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.
European archives of psychiatry and clinical neuroscience 2012;262(7):625-34.
2012: Leonhard Lennertz; Wolfgang Maier; Petra E Franke; Ingo Frommann; Wolfgang Gaebel; Heinz Häfner; Susanne Höfels; Joachim Klosterkötter; Martin W Landsberg; Nadine Petrovsky; Ralf Pukrop; Boris B Quednow; Anna Schuhmacher; Svenja Schulze-Rauschenbach; Anja Steinbrecher; Michael Wagner; Wolfgang Wölwer; Rainald Mössner
The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(9):1205-15.
2012: D Huys; E-H Kim; Joachim Klosterkötter; K Hardenacke; W Huff; M Möller; Lars Timmermann; Christiane Woopen; Jens Kuhn
[Deep brain stimulation for psychiatric disorders: historical basis].
Der Nervenarzt 2012;83(9):1156-68.
2012: Ilja Spellmann; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Richard Musil; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Rebecca Schennach; Max Schmauß; Lutz G Schmidt; Florian Seemüller; Hans-Jürgen Möller
One-year functional outcomes of naturalistically treated patients with schizophrenia.
Psychiatry research 2012;198(3):378-85.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Richard Musil; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
Schizophrenia research 2012;139(1-3):218-24.
2012: Frauke Schultze-Lutter; Benno Graf Schimmelmann; Joachim Klosterkötter; Stephan Ruhrmann
Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features.
Schizophrenia research 2012;138(2-3):218-22.
2012: Raimo K R Salokangas; Frauke Schultze-Lutter; Tanja Svirskis; Heinrich Graf von Reventlow; Max Birchwood; Peter M A J Dingemans; Tiina From; Markus Heinimaa; Georg Juckel; Joachim Klosterkötter; Don Linszen; Sinikka Luutonen; Paul Patterson; Stephan Ruhrmann
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
Schizophrenia research 2012;138(2-3):192-7.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.
The Psychiatric quarterly 2012;83(2):187-207.
2012: R K R Salokangas; Tanja Svirskis; L Vaskelainen; H G von Reventlow; Max Birchwood; P Dingemans; T From; Markus Heinimaa; G Juckel; Joachim Klosterkötter; Don Linszen; P Patterson; S Ruhrmann
Perceived negative attitude of others predicts transition to psychosis in patients at risk of psychosis.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(4):264-6.
2012: R Müller; Toni Schneider; H Struck; Anke Brockhaus-Dumke; Karl Broich; J Hescheler; M S P Ho; Joachim Klosterkötter; Marco Weiergräber
Atropine-sensitive hippocampal θ oscillations are mediated by Cav2.3 R-type Ca²⁺ channels.
Neuroscience 2012;205():125-39.
2012: Leonhard Lennertz; Wolfgang Maier; Ralf Pukrop; Stephan Ruhrmann; Anna Schuhmacher; Svenja Schulze-Rauschenbach; Anja Steinbrecher; Michael Wagner; Wolfgang Wölwer; Michael Alexander; Andreas Bechdolf; Julia Berning; Petra E Franke; Ingo Frommann; Wolfgang Gaebel; Heinz Häfner; Joachim Klosterkötter; Martin W Landsberg; Rainald Mössner
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.
European archives of psychiatry and clinical neuroscience 2012;262(2):117-24.
2012: Jens Kuhn; Theo O J Gruendler; Joachim Klosterkötter; Christina Bartsch
Stimulating the addictive brain.
Frontiers in human neuroscience 2012;6():220.
2012: F. Markus Leweke; D Muhl; F Pahlisch; Daniele Piomelli; Christoph W Gerth; Martin Hellmich; C Hoyer; Joachim Klosterkötter; Dagmar Koethe
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Translational psychiatry 2012;2():e94.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
Psychopathology 2012;45(5):276-85.
2012: Stephan Ruhrmann; Benno Graf Schimmelmann; Andreas Bechdolf; Mitja Bodatsch; Desiree Hilboll; Joachim Klosterkötter; Alexandra Nikolaides; Frauke Schultze-Lutter
Pharmacological prevention and treatment in clinical at-risk states for psychosis.
Current pharmaceutical design 2012;18(4):550-7.
2012: Andreas Bechdolf; M Berk; A M Chanen; Philippe Conus; S M Cotton; P Fusar Poli; Joachim Klosterkötter; B Nelson; A Ratheesh; Stephan Ruhrmann; Frauke Schultze-Lutter; T Tecic; S J Wood; A R Yung; G Paul Amminger; Patrick D McGorry
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder.
Current pharmaceutical design 2012;18(4):358-75.
2012: Frauke Schultze-Lutter; Andreas Bechdolf; Paolo Fusar-Poli; Stephan Ruhrmann; Benno Graf Schimmelmann; Joachim Klosterkötter
Basic symptoms and the prediction of first-episode psychosis.
Current pharmaceutical design 2012;18(4):351-7.
2012: S Dragt; P French; H Graf von Reventlow; Markus Heinimaa; A Heinz; G Juckel; Joachim Klosterkötter; Don Linszen; Dorien Nieman; P Patterson; Stephan Ruhrmann; R K R Salokangas; Frauke Schultze-Lutter; H Stevens; F van der Meer; H Becker; Max Birchwood; Lieuwe de Haan; Peter M A J Dingemans
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
Acta psychiatrica Scandinavica 2012;125(1):45-53.
2012: Michael Riedel; Heinrich Sauer; Andrea Schmitt; Frank Schneider; Florian Seemüller; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Wolfgang Maier; Andreas Mayr; Hans-Jürgen Möller; Rebecca Schennach-Wolff
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2012;13(1):30-8.
2011: Rebecca Schennach-Wolff; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Journal of psychiatric research 2011;45(12):1639-47.
2011: J Kuhn; Doris Lenartz; V Sturm; P J Uhlhaas; C Winter; M Bodatsch; Joachim Klosterkötter; T O J Gründler
[Deep brain stimulation in schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2011;79(11):632-41.
2011: Jens Kuhn; Doris Lenartz; Mohammad Maarouf; Robert Bauer; Christian Bührle; Adrian G Fischer; Theo O J Gründler; Wolfgang Huff; Joachim Klosterkötter; Markus Ullsperger; Volker Sturm
Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring.
Addiction biology 2011;16(4):620-3.
2011: Andreas Bechdolf; Martin Brüne; Walter de Millas; Wolfgang Gaebel; Andreas Heinz; Birgit Janssen; Joachim Klosterkötter; Seza Krüger-Özgürdal; Martin Lambert; Marion Lautenschlager; Wolfgang Maier; Tanja Maria Michel; Hendrik Müller; Dieter Naber; Michael Riedel; Frank Schneider; Hartmut Stützer; Michael Wagner; Thomas Wobrock
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Schizophrenia bulletin 2011;37 Suppl 2():S111-21.
2011: R Schennach-Wolff; Lutz G Schmidt; Florian Seemüller; E Rüther; Gerhard Buchkremer; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; T Messer; Hans-Jürgen Möller; D Naber; M Obermeier; H Pfeiffer; Michael Riedel
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(5):284-92.
2011: Ingo Frommann; Wolfgang Gaebel; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Ralf Pukrop; Michael Riedel; Stephan Ruhrmann; Andreas Bechdolf; Julia Berning; Jürgen Brinkmeyer; Petra Decker; Wolfgang Wölwer; Michael Wagner
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.
Schizophrenia bulletin 2011;37(4):861-73.
2011: Mitja Bodatsch; Stephan Ruhrmann; Michael Wagner; Ralf Müller; Frauke Schultze-Lutter; Ingo Frommann; Jürgen Brinkmeyer; Wolfgang Gaebel; Wolfgang Maier; Joachim Klosterkötter; Anke Brockhaus-Dumke
Prediction of psychosis by mismatch negativity.
Biological psychiatry 2011;69(10):959-66.
2011: Rebecca Schennach-Wolff; Markus Jäger; Andreas Mayr; Sebastian Meyer; Kai-Uwe Kühn; Stefan Klingberg; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Andrea Schmitt; Ralf Schlösser; Frank Schneider; Wolfgang Gaebel; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2011;21(5):370-8.
2011: R Schennach-Wolff; M Obermeier; Florian Seemüller; Markus Jäger; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Acta psychiatrica Scandinavica 2011;123(3):228-38.
2011: Jens Kuhn; Doris Lenartz; Mohammad Maarouf; C Bartsch; Joerg Daumann; Stefan Hunsche; D Huys; Joachim Klosterkötter; Christiane Woopen; Volker Sturm
Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome.
Translational psychiatry 2011;1():e52.
2011: Norbert Galldiks; I Kadow; Andreas Bechdolf; Gereon R Fink; Joachim Klosterkötter; J Kuhn
[Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
Fortschritte der Neurologie-Psychiatrie 2011;79(1):21-5.
2010: Rebecca Schennach-Wolff; Michael Obermeier; Florian Seemüller; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Rolf R Engel; Hans-Jürgen Möller; Michael Riedel
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Journal of clinical psychopharmacology 2010;30(6):726-31.
2010: Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Joachim Klosterkötter
Intervention in at-risk states for developing psychosis.
European archives of psychiatry and clinical neuroscience 2010;260 Suppl 2():S90-4.
2010: R Schennach-Wolff; Hans-Jürgen Möller; Markus Jäger; Florian Seemüller; M Obermeier; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Michael Riedel
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Pharmacopsychiatry 2010;43(7):245-51.
2010: Ralf Pukrop; Joachim Klosterkötter
Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence.
Neurotoxicity research 2010;18(3-4):272-86.
2010: Eva Velthorst; Dorien H Nieman; Don Linszen; Hiske Becker; Lieuwe de Haan; Peter M A J Dingemans; Max Birchwood; Paul Patterson; Raimo K R Salokangas; Markus Heinimaa; Andreas Heinz; Georg Juckel; Heinrich Graf von Reventlow; Paul French; Helen Stevens; Frauke Schultze-Lutter; Joachim Klosterkötter; Stephan Ruhrmann
Disability in people clinically at high risk of psychosis.
The British journal of psychiatry : the journal of mental science 2010;197(4):278-84.
2010: Rebecca Schennach-Wolff; Markus Jäger; Michael Obermeier; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(5):729-38.
2010: Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter
Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V.
Schizophrenia research 2010;120(1-3):23-37.
2010: C Hoyer; L Kranaster; F. Markus Leweke; Joachim Klosterkötter; Andreas Meyer-Lindenberg; D Koethe
Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.
Pharmacopsychiatry 2010;43(5):196-7.
2010: Katharina Pauly; Nina Seiferth; Thilo Kellermann; Stephan Ruhrmann; Bianca Daumann; Volker Backes; Joachim Klosterkötter; N Jon Shah; Frank Schneider; Tilo T J Kircher; Ute Habel
The interaction of working memory and emotion in persons clinically at risk for psychosis: an fMRI pilot study.
Schizophrenia research 2010;120(1-3):167-76.
2010: Rebecca Schennach-Wolff; Florian Hannes Seemüller; Andreas Mayr; Wolfgang Maier; Stefan Klingberg; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Heinz Häfner; H Sauer; Frank Schneider; Wolfgang Gaebel; Markus Jäger; Hans-Jürgen Möller; Michael Riedel
An early improvement threshold to predict response and remission in first-episode schizophrenia.
The British journal of psychiatry : the journal of mental science 2010;196(6):460-6.
2010: Leonhard Lennertz; Michael Wagner; Ingo Frommann; Svenja Schulze-Rauschenbach; Anna Schuhmacher; Kai-Uwe Kühn; Ralf Pukrop; Joachim Klosterkötter; Wolfgang Wölwer; Wolfgang Gaebel; Marcella Rietschel; Heinz Häfner; Wolfgang Maier; Rainald Mössner
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(6):414-20.
2010: Markus Jäger; Michael Riedel; M Obermeier; R Schennach-Wolff; Florian Seemüller; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; K-U Kühn; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Ronald Bottlender; Hans-Jürgen Möller
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
Schizophrenia research 2010;118(1-3):183-8.
2010: R Schennach-Wolff; Markus Jäger; Florian Seemüller; M Obermeier; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Acta psychiatrica Scandinavica 2010;121(5):359-70.
2010: Rainald Mössner; Anna Schuhmacher; Michael Wagner; Boris B Quednow; Ingo Frommann; Kai-Uwe Kühn; Sibylle G Schwab; Marcella Rietschel; Peter Falkai; Wolfgang Wölwer; Stephan Ruhrmann; Andreas Bechdolf; Wolfgang Gaebel; Joachim Klosterkötter; Wolfgang Maier
DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis.
European archives of psychiatry and clinical neuroscience 2010;260(3):209-15.
2010: Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
Archives of general psychiatry 2010;67(3):241-51.
2010: Jens Kuhn; Theo O J Gründler; Doris Lenartz; Volker Sturm; Joachim Klosterkötter; Wolfgang Huff
Deep brain stimulation for psychiatric disorders.
Deutsches Ärzteblatt international 2010;107(7):105-13.
2010: Wolfgang Huff; Doris Lenartz; Michael Schormann; Sun-Hee Lee; Jens Kuhn; Athanasios Koulousakis; Juergen Mai; Joerg Daumann; Mohammad Maarouf; Joachim Klosterkötter; Volker Sturm
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year.
Clinical neurology and neurosurgery 2010;112(2):137-43.
2010: Frauke Schultze-Lutter; Stephan Ruhrmann; Julia Berning; Wolfgang Maier; Joachim Klosterkötter
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.
Schizophrenia bulletin 2010;36(1):182-91.
2009: Markus Jäger; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; D Degner; Gerhard Buchkremer; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(8):501-6.
2009: Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Attitude towards adherence in patients with schizophrenia at discharge.
Journal of psychiatric research 2009;43(16):1294-301.
2009: Patrick D McGorry; Barnaby Nelson; G Paul Amminger; Andreas Bechdolf; Shona M Francey; Gregor Berger; Anita Riecher-Rössler; Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Merete Nordentoft; Ian Hickie; Philip McGuire; Michael Berk; Eric Yu Hai Chen; Matcheri S Keshavan; Alison R Yung
Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
The Journal of clinical psychiatry 2009;70(9):1206-12.
2009: Joachim Klosterkötter
[Early recognition and prevention of psychoses].
Fortschritte der Neurologie-Psychiatrie 2009;77(8):431.
2009: Thomas Wobrock; Oliver Gruber; Thomas Schneider-Axmann; Wolfgang Wölwer; Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Maier; Joachim Klosterkötter; Frank Schneider; Gerhard Buchkremer; Hans-Jürgen Möller; Andrea Schmitt; Stefan Bender; Ralf Schlösser; Peter Falkai
Internal capsule size associated with outcome in first-episode schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(5):278-83.
2009: Dagmar Koethe; Laura Kranaster; Carolin Hoyer; Sonja Gross; Miriam A Neatby; Frauke Schultze-Lutter; Stephan Ruhrmann; Joachim Klosterkötter; Martin Hellmich; F. Markus Leweke
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(4):195-202.
2009: Raimo K R Salokangas; Markus Heinimaa; Tanja Svirskis; Tiina Laine; Jukka Huttunen; Terja Ristkari; Tuula Ilonen; Jyrki Korkeila; Leena Vaskelainen; Jaakko Rekola; Jarmo Hietala; Joachim Klosterkötter; Stephan Ruhrmann; Heinrich Graf von Reventlow; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson
Perceived negative attitude of others as an early sign of psychosis.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(4):233-8.
2009: Dagmar Koethe; Andrea Giuffrida; Daniela Schreiber; Martin Hellmich; Frauke Schultze-Lutter; Stefan Ruhrmann; Joachim Klosterkötter; Daniele Piomelli; F. Markus Leweke
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.
The British journal of psychiatry : the journal of mental science 2009;194(4):371-2.
2009: Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter
Intervention in the at-risk state to prevent transition to psychosis.
Current opinion in psychiatry 2009;22(2):177-83.
2009: Dagmar Koethe; Daniela Schreiber; Andrea Giuffrida; Christian Mauss; Johannes Faulhaber; Bernd Heydenreich; Martin Hellmich; Rudolf Graf; Joachim Klosterkötter; Daniele Piomelli; F. Markus Leweke
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(3):301-5.
2009: Deborah Janowitz; Hans Joergen Grabe; Stephan Ruhrmann; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Ferber; Ralf Pukrop; Harald J Freyberger; Joachim Klosterkötter; Peter Falkai; Ulrich John; Wolfgang Maier; Michael Wagner
Early onset of obsessive-compulsive disorder and associated comorbidity.
Depression and anxiety 2009;26(11):1012-7.
2009: Frauke Schultze-Lutter; Stephan Ruhrmann; Joachim Klosterkötter
Early detection of psychosis - establishing a service for persons at risk.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(1):1-10.
2009: Nadine Petrovsky; Frank Weiss-Motz; Svenja Schulze-Rauschenbach; Matthias Lemke; Peter Hornung; Stephan Ruhrmann; Joachim Klosterkötter; Wolfgang Maier; Ulrich Ettinger; Michael Wagner
Antisaccade performance is related to genetic loading for schizophrenia.
Journal of psychiatric research 2009;43(3):291-7.
2009: Markus Jäger; Michael Riedel; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerd Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Prediction of symptom remission in schizophrenia during inpatient treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):426-34.
2008: Ingo Frommann; Jürgen Brinkmeyer; Stephan Ruhrmann; Eva Hack; Anke Brockhaus-Dumke; Andreas Bechdolf; Wolfgang Wölwer; Joachim Klosterkötter; Wolfgang Maier; Michael Wagner
Auditory P300 in individuals clinically at risk for psychosis.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2008;70(3):192-205.
2008: Hans-Jürgen Möller; Michael Riedel; Markus Jäger; Florian Wickelmaier; Wolfgang Maier; Kai-Uwe Kühn; Gerhard Buchkremer; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Dieter F Braus; Ralf Schlösser; Frank Schneider; Christian Ohmann; Mathias Riesbeck; Wolfgang Gaebel
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(7):985-97.
2008: Markus Jäger; T Messer; G Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Michael Riedel; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
Pharmacopsychiatry 2008;41(5):190-5.
2008: Joachim Klosterkötter
Indicated prevention of schizophrenia.
Deutsches Ärzteblatt international 2008;105(30):532-9.
2008: Joachim Klosterkötter; Frauke Schultze-Lutter; Stephan Ruhrmann
Kraepelin and psychotic prodromal conditions.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 2():74-84.
2008: Stephan Ruhrmann; J Paruch; Andreas Bechdolf; Ralf Pukrop; Michael Wagner; J Berning; Frauke Schultze-Lutter; Birgit Janssen; Wolfgang Gaebel; Hans-Jürgen Möller; Wolfgang Maier; Joachim Klosterkötter
Reduced subjective quality of life in persons at risk for psychosis.
Acta psychiatrica Scandinavica 2008;117(5):357-68.
2008: Susan Ettelt; Hans Joergen Grabe; Stephan Ruhrmann; Friederike Buhtz; Andrea Hochrein; Susanne Kraft; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Ulrich John; Harald J Freyberger; Michael Wagner
Harm avoidance in subjects with obsessive-compulsive disorder and their families.
Journal of affective disorders 2008;107(1-3):265-9.
2008: Nina Seiferth; Katharina Pauly; Ute Habel; Thilo Kellermann; N Jon Shah; Stephan Ruhrmann; Joachim Klosterkötter; Frank Schneider; Tilo T J Kircher
Increased neural response related to neutral faces in individuals at risk for psychosis.
NeuroImage 2008;40(1):289-97.
2008: Frauke Schultze-Lutter; Heinz Picker; Stephan Ruhrmann; Joachim Klosterkötter
[The Cologne Early Recognition and Intervention Center for mental crises (FETZ). Evaluation of service use].
Medizinische Klinik (Munich, Germany : 1983) 2008;103(2):81-9.
2008: Hans Joergen Grabe; Stephan Ruhrmann; Carsten Spitzer; Jana Josepeit; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Michael Wagner; Ulrich John; Harald J Freyberger
Obsessive-compulsive disorder and posttraumatic stress disorder.
Psychopathology 2008;41(2):129-34.
2008: Wolfgang Gaebel; Harald Zäske; Anja E Baumann; Joachim Klosterkötter; Wolfgang Maier; Petra Decker; Hans-Jürgen Möller
Evaluation of the German WPA "program against stigma and discrimination because of schizophrenia--Open the Doors": results from representative telephone surveys before and after three years of antistigma interventions.
Schizophrenia research 2008;98(1-3):184-93.
2007: Stephan Ruhrmann; Andreas Bechdolf; Kai-Uwe Kühn; M Wagner; Frauke Schultze-Lutter; Birgit Janssen; K Maurer; H Häfner; Wolfgang Gaebel; Hans-Jürgen Möller; Wolfgang Maier; Joachim Klosterkötter
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
The British journal of psychiatry. Supplement 2007;51():s88-95.
2007: Frauke Schultze-Lutter; Stephan Ruhrmann; Heinz Picker; Heinrich Graf von Reventlow; Anke Brockhaus-Dumke; Joachim Klosterkötter
Basic symptoms in early psychotic and depressive disorders.
The British journal of psychiatry. Supplement 2007;51():s31-7.
2007: Raguna Nagy; Juliane Heuckmann; Hans-Dieter Mennel; Joachim Klosterkötter; Jens Kuhn
[Frontotemporal dementia].
Medizinische Klinik (Munich, Germany : 1983) 2007;102(10):816-23.
2007: Frauke Schultze-Lutter; Stephan Ruhrmann; Carolin Hoyer; Joachim Klosterkötter; F. Markus Leweke
The initial prodrome of schizophrenia: different duration, different underlying deficits?
Comprehensive psychiatry 2007;48(5):479-88.
2007: F. Markus Leweke; Andrea Giuffrida; Dagmar Koethe; Daniela Schreiber; Brit M Nolden; Laura Kranaster; Miriam A Neatby; Miriam Schneider; Christoph W Gerth; Martin Hellmich; Joachim Klosterkötter; Daniele Piomelli
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
Schizophrenia research 2007;94(1-3):29-36.
2007: Dagmar Koethe; Antje Juelicher; Brit M Nolden; Wolf-Dietrich Braunwarth; Joachim Klosterkötter; Günter Niklewski; Norbert Wodarz; Jan Klatt; Wilhelm Burtscheidt; Wolfgang Gaebel; F Markus Leweke
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Alcoholism, clinical and experimental research 2007;31(7):1188-94.
2007: Anja Baumann; H Zäske; P Decker; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Wolfgang Gaebel
[Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004].
Der Nervenarzt 2007;78(7):787-8, 790-5.
2007: Ralf Pukrop; Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Anke Brockhaus-Dumke; Joachim Klosterkötter
Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis.
Schizophrenia research 2007;92(1-3):116-25.
2007: F. Markus Leweke; Christoph W Gerth; Dagmar Koethe; Brit M Nolden; Joachim Klosterkötter
[Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
Fortschritte der Neurologie-Psychiatrie 2007;75(4):211-9.
2007: Daniela Schreiber; Steffi Harlfinger; Brit M Nolden; Christoph W Gerth; Ulrich Jaehde; Edgar Schömig; Joachim Klosterkötter; Andrea Giuffrida; Giuseppe Astarita; Daniele Piomelli; F Markus Leweke
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry.
Analytical biochemistry 2007;361(2):162-8.
2007: Jeffrey T-J Huang; F. Markus Leweke; Tsz M Tsang; Dagmar Koethe; Laura Kranaster; Christoph W Gerth; Sonja Gross; Daniela Schreiber; Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter; Elaine Holmes; Sabine Bahn
CSF metabolic and proteomic profiles in patients prodromal for psychosis.
PloS one 2007;2(8):e756.
2007: Susan Ettelt; Stephan Ruhrmann; Sven Barnow; F Buthz; Andrea Hochrein; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Michael Wagner; Harald J Freyberger; Hans Joergen Grabe
Impulsiveness in obsessive-compulsive disorder: results from a family study.
Acta psychiatrica Scandinavica 2007;115(1):41-7.
2006: Dagmar Koethe; Christoph W Gerth; Miriam A Neatby; Anita Haensel; Martin Thies; Udo Schneider; Hinderk M Emrich; Joachim Klosterkötter; Frauke Schultze-Lutter; F. Markus Leweke
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
Schizophrenia research 2006;88(1-3):142-50.
2006: Hans Joergen Grabe; Stephan Ruhrmann; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Harald J Freyberger; Joachim Klosterkötter; Peter Falkai; Ulrich John; Wolfgang Maier; Michael Wagner
Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects.
The American journal of psychiatry 2006;163(11):1986-92.
2006: Ralf Pukrop; Frauke Schultze-Lutter; Stephan Ruhrmann; Anke Brockhaus-Dumke; Indira Tendolkar; Andreas Bechdolf; Eveline Matuschek; Joachim Klosterkötter
Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia.
Journal of clinical and experimental neuropsychology 2006;28(8):1388-407.
2006: A Wessling; Wolfgang Wölwer; Stephan Heres; M Mayenberger; Christine Rummel; M Sievers; M Wagner; Joachim Klosterkötter; Wolfgang Gaebel
[A telephone hotline as an easily accessible service for questions on schizophrenia].
Der Nervenarzt 2006;77(9):1105-6, 1108-10.
2006: Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Recent approaches to psychological interventions for people at risk of psychosis.
European archives of psychiatry and clinical neuroscience 2006;256(3):159-73.
2006: Joachim Klosterkötter
[For: "Every person with schizophrenia should be treated as early as possible"].
Psychiatrische Praxis 2006;33(3):105-6.
2006: Wolfgang Wölwer; Anja Baumann; Andreas Bechdolf; Gerhard Buchkremer; Heinz Häfner; Birgit Janssen; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Stephan Ruhrmann; Wolfgang Gaebel
The German Research Network on Schizophrenia--impact on the management of schizophrenia.
Dialogues in clinical neuroscience 2006;8(1):115-21.
2005: Andreas Bechdolf; B Pohlmann; C Geyer; C Ferber; Joachim Klosterkötter; Euphrosyne Gouzoulis-Mayfrank
[Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].
Fortschritte der Neurologie-Psychiatrie 2005;73(12):728-35.
2005: Andreas Bechdolf; Ralf Pukrop; Daniel Köhn; Stefanie Tschinkel; Verena Veith; Frauke Schultze-Lutter; Stephan Ruhrmann; Caroline Geyer; Bettina Pohlmann; Joachim Klosterkötter
Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls.
Schizophrenia research 2005;79(1):137-43.
2005: Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Don Linszen; Max Birchwood; Georg Juckel; Anthony Morrison; José Luis Vázquèz-Barquero; Martin Hambrecht; Heinrich VON Reventlow
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2005;4(3):161-7.
2005: Andreas Bechdolf; Verena Veith; Dirk Schwarzer; Michael Schormann; Elmar Stamm; Birgit Janssen; Julia Berning; Michael Wagner; Joachim Klosterkötter
Cognitive-behavioral therapy in the pre-psychotic phase: an exploratory study.
Psychiatry research 2005;136(2-3):251-5.
2005: Andreas Bechdolf; Daniel Köhn; Bärbel Knost; Ralf Pukrop; Joachim Klosterkötter
A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months.
Acta psychiatrica Scandinavica 2005;112(3):173-9.
2005: Andreas Bechdolf; Stephan Ruhrmann; Michael Wagner; Kai-Uwe Kühn; Birgit Janssen; Ronald Bottlender; Anke Wieneke; Frauke Schulze-Lutter; Wolfgang Maier; Joachim Klosterkötter
Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment.
The British journal of psychiatry. Supplement 2005;48():s45-8.
2005: Lisa J Phillips; Patrick D McGorry; Alison R Yung; Thomas H McGlashan; Barbara Cornblatt; Joachim Klosterkötter
Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities.
The British journal of psychiatry. Supplement 2005;48():s33-44.
2005: Joachim Klosterkötter
[What is the effect of trauma in post traumatic stress disorder?].
Fortschritte der Neurologie-Psychiatrie 2005;73(7):375-6.
2005: Indira Tendolkar; Stephan Ruhrmann; Anke Brockhaus-Dumke; Monika Pauli; Ralf Mueller; Ralf Pukrop; Joachim Klosterkötter
Neural correlates of visuo-spatial attention during an antisaccade task in schizophrenia: an ERP study.
The International journal of neuroscience 2005;115(5):681-98.
2005: Anke Brockhaus-Dumke; Indira Tendolkar; Ralf Pukrop; Frauke Schultze-Lutter; Joachim Klosterkötter; Stephan Ruhrmann
Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia.
Schizophrenia research 2005;73(2-3):297-310.
2005: Stephan Ruhrmann; Frauke Schultze-Lutter; Wolfgang Maier; Joachim Klosterkötter
Pharmacological intervention in the initial prodromal phase of psychosis.
European psychiatry : the journal of the Association of European Psychiatrists 2005;20(1):1-6.
2004: Daniel Köhn; Ralf Pukrop; Antje Niedersteberg; Frauke Schultze-Lutter; Stephan Ruhrmann; Andreas Bechdolf; Julia Berning; Wolfgang Maier; Joachim Klosterkötter
[Pathways to care: help-seeking behavior in first-episode psychosis].
Fortschritte der Neurologie-Psychiatrie 2004;72(11):635-42.
2004: Andrea Giuffrida; F. Markus Leweke; Christoph W Gerth; Daniela Schreiber; Dagmar Koethe; Johannes Faulhaber; Joachim Klosterkötter; Daniele Piomelli
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(11):2108-14.
2004: Indira Tendolkar; Susanne Weis; Oliver Guddat; Guillén Fernández; Anke Brockhaus-Dumke; Karsten Specht; Joachim Klosterkötter; Jürgen Reul; Stephan Ruhrmann
Evidence for a dysfunctional retrosplenial cortex in patients with schizophrenia: a functional magnetic resonance imaging study with a semantic-perceptual contrast.
Neuroscience letters 2004;369(1):4-8.
2004: Andreas Bechdolf; Bärbel Knost; C Kuntermann; S Schiller; Joachim Klosterkötter; Martin Hambrecht; Ralf Pukrop
A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia.
Acta psychiatrica Scandinavica 2004;110(1):21-8.
2004: Indira Tendolkar; Stephan Ruhrmann; Anke Brockhaus; David Donaldson; Karin Wirtz; Guillén Fernández; Joachim Klosterkötter
Neural correlates of temporal context discrimination.
Biological psychology 2004;66(3):235-55.
2004: Heinz Häfner; Kurt Maurer; Stephan Ruhrmann; Andreas Bechdolf; Joachim Klosterkötter; Michael Wagner; Wolfgang Maier; Ronald Bottlender; Hans-Jürgen Möller; Wolfgang Gaebel; Wolfgang Wölwer
Early detection and secondary prevention of psychosis: facts and visions.
European archives of psychiatry and clinical neuroscience 2004;254(2):117-28.
2004: F. Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Antibodies to infectious agents in individuals with recent onset schizophrenia.
European archives of psychiatry and clinical neuroscience 2004;254(1):4-8.
2004: Daniel Köhn; Antje Niedersteberg; Anke Wieneke; Andreas Bechdolf; Ralf Pukrop; Stephan Ruhrmann; Frauke Schultze-Lutter; Wolfgang Maier; Joachim Klosterkötter
[Early course of illness in first episode schizophrenia with long duration of untreated illness - a comparative study].
Fortschritte der Neurologie-Psychiatrie 2004;72(2):88-92.
2004: F. Markus Leweke; Christoph W Gerth; Joachim Klosterkötter
Cannabis-associated psychosis: current status of research.
CNS drugs 2004;18(13):895-910.
2003: Volker Sturm; Doris Lenartz; Athanasios Koulousakis; Harald Treuer; Karl Herholz; Johannes Christian Klein; Joachim Klosterkötter
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders.
Journal of chemical neuroanatomy 2003;26(4):293-9.
2003: Wolfgang Wölwer; Gerhard Buchkremer; Heinz Häfner; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Wolfgang Gaebel
German research network on schizophrenia-bridging the gap between research and care.
European archives of psychiatry and clinical neuroscience 2003;253(6):321-9.
2003: Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter
Early detection and intervention in the initial prodromal phase of schizophrenia.
Pharmacopsychiatry 2003;36 Suppl 3():S162-7.
2003: Andreas Bechdolf; Joachim Klosterkötter; Martin Hambrecht; Bärbel Knost; Christina Kuntermann; Sabine Schiller; Ralf Pukrop
Determinants of subjective quality of life in post acute patients with schizophrenia.
European archives of psychiatry and clinical neuroscience 2003;253(5):228-35.
2003: Ralf Pukrop; Eveline Matuschek; Stephan Ruhrmann; Anke Brockhaus-Dumke; Indira Tendolkar; Alexandra Bertsch; Joachim Klosterkötter
Dimensions of working memory dysfunction in schizophrenia.
Schizophrenia research 2003;62(3):259-68.
2003: Ralf Pukrop; Volker Schlaak; Anne Maria Möller-Leimkühler; Margot Albus; Adelheid Czernik; Joachim Klosterkötter; Hans-Jürgen Möller
Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression.
Psychiatry research 2003;119(1-2):63-79.
2003: Peter A Tass; Joachim Klosterkötter; Frank Schneider; Doris Lenartz; Athanasios Koulousakis; Volker Sturm
Obsessive-compulsive disorder: development of demand-controlled deep brain stimulation with methods from stochastic phase resetting.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28 Suppl 1():S27-34.
2002: Eckhard M Steinmeyer; Joachim Klosterkötter; Hans-Jürgen Möller; Henning Sass; Stephan Herpertz; Adelheid Czernik; J T Marcea; F Matakas; J Mehne; H Bottländer; W Hesse; I Steinbring; Ralf Pukrop
[Personality and personality disorders II. The Specificity of the DAPP-model as a diagnostic system for personality disorders].
Fortschritte der Neurologie-Psychiatrie 2002;70(12):641-6.
2002: Eckhard M Steinmeyer; Joachim Klosterkötter; Hans-Jürgen Möller; Henning Sass; Stephan Herpertz; Adelheid Czernik; J T Marcea; F Matakas; J Mehne; H Bottländer; W Hesse; I Steinbring; Ralf Pukrop
[Personality and personality disorders I. Universality and sensitivity of dimensional personality models as diagnostic systems for personality disorders].
Fortschritte der Neurologie-Psychiatrie 2002;70(12):630-40.
2002: Eckhard M Steinmeyer; Joachim Klosterkötter
[Current models of personality and their empirical evaluation].
Fortschritte der Neurologie-Psychiatrie 2002;70(12):625-9.
2002: Andreas Bechdolf; Frauke Schultze-Lutter; Joachim Klosterkötter
Self-experienced vulnerability, prodromal symptoms and coping strategies preceding schizophrenic and depressive relapses.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17(7):384-93.
2002: Indira Tendolkar; Stephan Ruhrmann; A Brockhaus; Ralf Pukrop; Joachim Klosterkötter
Remembering or knowing: electrophysiological evidence for an episodic memory deficit in schizophrenia.
Psychological medicine 2002;32(7):1261-71.
2002: Martin Hambrecht; Michael Lammertink; Joachim Klosterkötter; Eveline Matuschek; Ralf Pukrop
Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic.
The British journal of psychiatry. Supplement 2002;43():s30-7.
2002: Ralf Pukrop; Eckhard M Steinmeyer; M Woschnik; Adelheid Czernik; H Matthies; Henning Sass; Joachim Klosterkötter
[Personality, accentuated traits and personality disorders. A contribution to dimensional diagnosis of personality disorders].
Der Nervenarzt 2002;73(3):247-54.
2001: Joachim Klosterkötter; Frauke Schultze-Lutter
[Is there a primary prevention of schizophrenic psychiasis?].
Fortschritte der Neurologie-Psychiatrie 2001;69 Suppl 2():S104-12.
2001: Joachim Klosterkötter; M Hellmich; Eckhard M Steinmeyer; Frauke Schultze-Lutter
Diagnosing schizophrenia in the initial prodromal phase.
Archives of general psychiatry 2001;58(2):158-64.
2000: Joachim Klosterkötter; M Hellmich; Frauke Schultze-Lutter
[Is the diagnosis of schizophrenic illness possible in the initial prodromal phase to the first psychotic manifestation?].
Fortschritte der Neurologie-Psychiatrie 2000;68 Suppl 1():S13-21.
1999: Joachim Klosterkötter
[Psychiatric classification. Basic idea and development of an ongoing process].
Fortschritte der Neurologie-Psychiatrie 1999;67(12):558-73.
1999: Joachim Klosterkötter
[Cognition and psychopathology in schizophrenia].
Fortschritte der Neurologie-Psychiatrie 1999;Suppl 2():S44-52.
1999: Ralf Pukrop; Hans-Jürgen Möller; Henning Sass; Heinrich Sauer; Joachim Klosterkötter; Adelheid Czernik; Michael Krausz; R D Stieglitz; M Lambert; H Matthies; A Schaub; M Woschnik; F Wulfinghoff; Eckhard M Steinmeyer
[Quality of life. Construct validation and the development of a modular system].
Der Nervenarzt 1999;70(1):41-53.
1998: Andreas Bechdolf; S Halve; Frauke Schultze-Lutter; Joachim Klosterkötter
[Self-experienced vulnerability, prodromic symptoms and coping strategies before schizophrenic and affective episodes].
Fortschritte der Neurologie-Psychiatrie 1998;66(8):378-86.
1998: Joachim Klosterkötter
[From fighting to preventing disease. Is such a paradigm possible for schizophrenic disorders?].
Fortschritte der Neurologie-Psychiatrie 1998;66(8):366-77.
1998: Joachim Klosterkötter
[The revised definitions of schizophrenic disorders in ICD-10 and DSM-IV].
Fortschritte der Neurologie-Psychiatrie 1998;66(3):133-43.
1997: Joachim Klosterkötter; G Gross; G Huber; Eckhard M Steinmeyer
[Are self-perceivable neuropsychological deficits in patients with neuroses or personality disorder diagnoses indicative of later schizophrenia?].
Der Nervenarzt 1997;68(3):196-204.
1996: V Eichert; Joachim Klosterkötter
[Analysis of reaction time in post-acute schizophrenia using electrophysiologic variables].
Fortschritte der Neurologie-Psychiatrie 1996;64(7):261-70.
1996: T Lohmann; K Nishimura; Osama Sabri; Joachim Klosterkötter
[Successful electroconvulsive therapy of Cotard syndrome with bitemporal hypoperfusion].
Der Nervenarzt 1996;67(5):400-3.
1996: Joachim Klosterkötter; Hermann Ebel; Frauke Schultze-Lutter; Eckhard M Steinmeyer
Diagnostic validity of basic symptoms.
European archives of psychiatry and clinical neuroscience 1996;246(3):147-54.
1995: Joachim Klosterkötter; M Albers; Eckhard M Steinmeyer; A Hensen; Henning Sass
Positive or negative symptoms--which are more appropriate as diagnostic criteria for schizophrenia?
Acta psychiatrica Scandinavica 1995;92(5):321-6.
1994: Joachim Klosterkötter; M Albers; Eckhard M Steinmeyer; A Hensen; Henning Sass
[Positive or negative symptoms. Which are more reliable in the diagnosis of schizophrenia?].
Der Nervenarzt 1994;65(7):444-53.
1992: Joachim Klosterkötter
[How does the schizophrenic nuclear syndrome arise? Results of the Bonn transition series study and Anglo-American models--a comparison].
Der Nervenarzt 1992;63(11):675-82.
1992: Joachim Klosterkötter
The meaning of basic symptoms for the genesis of the schizophrenic nuclear syndrome.
The Japanese journal of psychiatry and neurology 1992;46(3):609-30.
1992: Hermann Ebel; U Schlegel; Joachim Klosterkötter
[Chronic schizophreniform psychosis in primary hyperparathyroidism].
Der Nervenarzt 1992;63(3):180-3.
1990: Marie Luise Rao; G Gross; B Strebel; Peter Bräunig; G Huber; Joachim Klosterkötter
Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
Psychiatry research 1990;34(3):243-57.
1990: G Gross; G Huber; Joachim Klosterkötter; Marie Luise Rao; M Linz
[Status-dependent neurochemical parameters in schizophrenic and affective diseases].
Fortschritte der Neurologie-Psychiatrie 1990;58(4):154-60.
1989: Joachim Klosterkötter; G Gross; G Huber
[The concept of process activity in idiopathic psychoses].
Der Nervenarzt 1989;60(12):740-4.
1989: Joachim Klosterkötter
[Changes in the paradigms of psychopathology].
Der Nervenarzt 1989;60(6):319-31.
1989: G Huber; G Gross; Joachim Klosterkötter
[Concepts and criteria of affective psychoses].
Der Nervenarzt 1989;60(2):90-4.
1989: Joachim Klosterkötter; H Penin
[Epileptic psychoses and their drug treatment].
Fortschritte der Neurologie-Psychiatrie 1989;57(2):61-9.
1989: Hermann Ebel; G Gross; Joachim Klosterkötter; G Huber
Basic symptoms in schizophrenic and affective psychoses.
Psychopathology 1989;22(4):224-32.